HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,262,319 | +3.0% | 137,739 | -2.7% | 1.25% | +14.1% |
Q2 2023 | $5,106,827 | +15.9% | 141,581 | +22.6% | 1.10% | +12.5% |
Q1 2023 | $4,408,067 | -37.9% | 115,470 | -7.3% | 0.97% | -38.9% |
Q4 2022 | $7,098,112 | +19.1% | 124,572 | -17.4% | 1.59% | +15.7% |
Q3 2022 | $5,961,000 | -21.2% | 150,755 | -12.3% | 1.38% | -13.5% |
Q2 2022 | $7,568,000 | -35.5% | 171,969 | -41.6% | 1.59% | -9.4% |
Q1 2022 | $11,737,000 | -1.3% | 294,413 | -0.4% | 1.76% | +13.4% |
Q4 2021 | $11,890,000 | – | 295,656 | – | 1.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |